Serotypes and antibiotic resistance in Group B streptococcus isolated from patients at the Maternity Hospital, Kuwait Free

Abstract

A total of 143 group B streptococcus (GBS) isolates collected from mothers at the Maternity Hospital in Kuwait were investigated for their serotypes and antibiotic resistance, and screened by PCR for the carriage of genes for resistance to tetracycline (, , , ), erythromycin (, , , , , , , ) and aminoglycosides (, , . All isolates were serotyped using a latex agglutination test. Most of the isolates belonged to serotypes V (38.5 %), III (20.9 %), Ia (7.7 %) and II (11.2 %). Sixteen isolates (11.2 %) were nontypable. All isolates were susceptible to penicillin, ampicillin and cefotaxime (MICs 0.016–0.094 µg ml) but were resistant to trimethoprim (92.3 %), tetracycline (89.5 %), minocycline (89.5 %), high-level kanamycin (76.9 %), chloramphenicol (30.0 %), erythromycin (12.6 %), clindamycin (7.0 %), high-level streptomycin (3.5 %) and ciprofloxacin (0.7 %). The tetracycline-resistant isolates contained (94.5 %), (3.9 %), (1.6 %) and (0.8 %). The erythromycin-resistant isolates contained (61.1 %), (38.9 %), (5.5 %), (5.5 %) and (11 %). All high-level kanamycin-resistant isolates contained One of the high-level streptomycin-resistant isolates contained . Partial DNA sequencing of revealed sequences with 99 % similarity to found in , , and , suggesting that the GBS isolates could have acquired from other Gram-positive cocci. The high proportion of isolates with resistance to tetracycline, high-level kanamycin and trimethoprim, and the increase in the prevalence of erythromycin resistance, represents an emerging public health concern that needs further surveillance.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.035477-0
2012-01-01
2024-03-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/61/1/126.html?itemId=/content/journal/jmm/10.1099/jmm.0.035477-0&mimeType=html&fmt=ahah

References

  1. Acikgoz Z. C., Almayanlar E., Gamberzade S., Gocer S. 2004; Macrolide resistance determinants of invasive and noninvasive group B streptococci in a Turkish hospital. Antimicrob Agents Chemother 48:1410–1412 [View Article][PubMed]
    [Google Scholar]
  2. Al-Sweih N., Hammoud M., Al-Shimmiri M., Jamal M., Neil L., Rotimi V. 2005a; Serotype distribution and mother-to-baby transmission rate of Streptococcus agalactiae among expectant mothers in Kuwait. Arch Gynecol Obstet 272:131–135 [View Article][PubMed]
    [Google Scholar]
  3. Al-Sweih N., Jamal M., Kurdia M., Abduljabar R., Rotimi V. 2005b; Antibiotic susceptibility profile of group B streptococcus (Streptococcus agalactiae) at the maternity hospital, Kuwait. Med Princ Pract 14:260–263 [View Article][PubMed]
    [Google Scholar]
  4. Amin A., Abdulrazzaq Y. M., Uduman S. 2002; Group B streptococcal serotype distribution of isolates from colonized pregnant women at the time of delivery in United Arab Emirates. J Infect 45:42–46 [View Article][PubMed]
    [Google Scholar]
  5. Aracil B., Miñambres M., Oteo J., De La Rosa M., Gómez-Garcés J. L., Alós A. J. 2002; Susceptibility of strains of Streptococcus agalactiae to macrolides and lincosamides, phenotype patterns and resistance genes. Clin Microbiol Infect 8:745–748 [View Article][PubMed]
    [Google Scholar]
  6. Baker C. J. 1979; Group B streptococcus in neonates. Pediatr Rev 1:5–15 [View Article]
    [Google Scholar]
  7. Benson J. A., Ferrieri P. 2001; Rapid pulsed-field gel electrophoresis method for group B streptococcus isolates. J Clin Microbiol 39:3006–3008 [View Article][PubMed]
    [Google Scholar]
  8. Betriu C., Culebras E., Gómez M., Rodríguez-Avial I., Sánchez B. A., Agreda M. C., Picazo J. J. 2003; Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae . Antimicrob Agents Chemother 47:1112–1114 [View Article][PubMed]
    [Google Scholar]
  9. Biedenbach D. J., Toleman M. A., Walsh T. R., Jones R. N. 2006; Characterization of fluoroquinolone-resistant β-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997–2004). Diagn Microbiol Infect Dis 55:119–127 [View Article][PubMed]
    [Google Scholar]
  10. Brimil N., Barthell E., Heindrichs U., Kuhn M., Lütticken R., Spellerberg B. 2006; Epidemiology of Streptococcus agalactiae colonization in Germany. Int J Med Microbiol 296:39–44 [View Article][PubMed]
    [Google Scholar]
  11. Castor M. L., Whitney C. G., Como-Sabetti K., Facklam R. R., Ferrieri P., Bartkus J. M., Juni B. A., Cieslak P. R., Farley M. M. other authors 2008; Antibiotic resistance patterns in invasive group B streptococcal isolates. Infect Dis Obstet Gynecol http://dx.doi.org/10.1155/2008/727505 (Epub ahead of print) [PubMed]
    [Google Scholar]
  12. Chu Y. W., Tse C., Tsang G. K. L., So D. K. S., Fung J. T. L., Lo J. Y. C. 2007; Invasive group B Streptococcus isolates showing reduced susceptibility to penicillin in Hong Kong. J Antimicrob Chemother 60:1407–1409 [View Article][PubMed]
    [Google Scholar]
  13. CLSI 2005; Performance Standards for Antimicrobial Susceptibility Testing, 15th supplement, M100–S15. Wayne, PA: Clinical and Laboratory Standards Institute;
  14. Dahesh S., Hensler M. E., Van Sorge N. M., Gertz R. E. Jr, Schrag S., Nizet V., Beall B. W. 2008; Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to β-lactam antibiotics. Antimicrob Agents Chemother 52:2915–2918 [View Article][PubMed]
    [Google Scholar]
  15. de Azavedo J. C. S., McGavin M., Duncan C., Low D. E., McGeer A. 2001; Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother 45:3504–3508 [View Article][PubMed]
    [Google Scholar]
  16. De Mouy D., Cavallo J.-D., Leclercq R., Fabre R. The Aforcopi-Bio Network 2001; Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae: French multicenter study. Antimicrob Agents Chemother 45:2400–2402 [View Article][PubMed]
    [Google Scholar]
  17. Diekema D. J., Andrews J. I., Huynh H., Rhomberg P. R., Doktor S. R., Beyer J., Shortridge V. D., Flamm R. K., Jones R. N., Pfaller M. A. 2003; Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci. J Clin Microbiol 41:2659–2661 [View Article][PubMed]
    [Google Scholar]
  18. Dogan B., Schukken Y. H., Santisteban C., Boor K. J. 2005; Distribution of serotypes and antimicrobial resistance genes among Streptococcus agalactiae isolates from bovine and human hosts. J Clin Microbiol 43:5899–5906 [View Article][PubMed]
    [Google Scholar]
  19. Duarte R. S., Bellei B. C., Miranda O. P., Brito M. A. V. P., Teixeira L. M. 2005; Distribution of antimicrobial resistance and virulence-related genes among Brazilian group B streptococci recovered from bovine and human sources. Antimicrob Agents Chemother 49:97–103 [View Article][PubMed]
    [Google Scholar]
  20. Figueira-Coelho J., Ramirez M., Salgado M. J., Melo-Cristino J. 2004; Streptococcus agalactiae in a large Portuguese teaching hospital: antimicrobial susceptibility, serotype distribution, and clonal analysis of macrolide-resistant isolates. Microb Drug Resist 10:31–36 [View Article][PubMed]
    [Google Scholar]
  21. Harrison L. H., Elliott J. A., Dwyer D. M., Libonati J. P., Ferrieri P., Billmann L., Schuchat A. 1998; Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program. J Infect Dis 177:998–1002[PubMed] [CrossRef]
    [Google Scholar]
  22. High K. P., Edwards M. S., Baker C. J. 2005; Group B streptococcal infections in elderly adults. Clin Infect Dis 41:839–847 [View Article][PubMed]
    [Google Scholar]
  23. Hsueh P. R., Teng L. J., Lee L. N., Ho S. W., Yang P. C., Luh K. T. 2001; High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. Antimicrob Agents Chemother 45:3205–3208 [View Article][PubMed]
    [Google Scholar]
  24. Kimura K., Suzuki S., Wachino J., Kurokawa H., Yamane K., Shibata N., Nagano N., Kato H., Shibayama K., Arakawa Y. 2008; First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother 52:2890–2897 [View Article][PubMed]
    [Google Scholar]
  25. Lachenauer C. S., Kasper D. L., Shimada J., Ichiman Y., Ohtsuka H., Kaku M., Paoletti L. C., Ferrieri P., Madoff L. C. 1999; Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J Infect Dis 179:1030–1033 [View Article][PubMed]
    [Google Scholar]
  26. Lopardo H. A., Vidal P., Jeric P., Centron D., Paganini H., Facklam R. R. The Argentinian Streptococcus Study Group Elliott J. 2003; Six-month multicenter study on invasive infections due to group B streptococci in Argentina. J Clin Microbiol 41:4688–4694 [View Article][PubMed]
    [Google Scholar]
  27. Mansouri S., Ghasami E., Shahabi Najad N. 2008; Vaginal colonization of group B streptococci during late pregnancy in southeast of Iran: incidence, serotype distribution and susceptibility to antibiotics. J Med Sci 8:574–578 [View Article]
    [Google Scholar]
  28. Marimón J. M., Valiente A., Ercibengoa M., García-Arenzana J. M., Pérez-Trallero E. 2005; Erythromycin resistance and genetic elements carrying macrolide efflux genes in Streptococcus agalactiae . Antimicrob Agents Chemother 49:5069–5074 [View Article][PubMed]
    [Google Scholar]
  29. Nagano N., Nagano Y., Kimura K., Tamai K., Yanagisawa H., Arakawa Y. 2008; Genetic heterogeneity in pbp genes among clinically isolated group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother 52:4258–4267 [View Article][PubMed]
    [Google Scholar]
  30. Nishimoto Y., Kobayashi N., Alam M. M., Ishino M., Uehara N., Watanabe N. 2005; Analysis of the prevalence of tetracycline resistance genes in clinical isolates of Enterococcus faecalis and Enterococcus faecium in a Japanese hospital. Microb Drug Resist 11:146–153 [View Article][PubMed]
    [Google Scholar]
  31. Persson E., Berg S., Trollfors B., Larsson P., Ek E., Backhaus E., Claesson B. E., Jonsson L., Rådberg G. other authors 2004; Serotypes and clinical manifestations of invasive group B streptococcal infections in western Sweden 1998–2001. Clin Microbiol Infect 10:791–796 [View Article][PubMed]
    [Google Scholar]
  32. Poyart C., Jardy L., Quesne G., Berche P., Trieu-Cuot P. 2003; Genetic basis of antibiotic resistance in Streptococcus agalactiae strains isolated in a French hospital. Antimicrob Agents Chemother 47:794–797 [View Article][PubMed]
    [Google Scholar]
  33. Pylipow M., Gaddis M., Kinney J. S. 1994; Selective intrapartum prophylaxis for group B streptococcus colonization: management and outcome of newborns. Pediatrics 93:631–635
    [Google Scholar]
  34. Roberts M. C., Sutcliffe J., Courvalin P., Jensen L. B., Rood J., Seppala H. 1999; Nomenclature for macrolides and macrolides–lincosamine-streptogramin B resistance determinants. Antimicrob Agents Chemother 43:2823–2829
    [Google Scholar]
  35. Rubens C. E., Wessels M. R., Heggen L. M., Kasper D. L. 1987; Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence. Proc Natl Acad Sci U S A 84:7208–7212 [View Article][PubMed]
    [Google Scholar]
  36. Slotved H. C., Kong F., Lambertsen L., Sauer S., Gilbert G. L. 2007; Serotype IX, a proposed new Streptococcus agalactiae serotype. J Clin Microbiol 45:2929–2936 [View Article][PubMed]
    [Google Scholar]
  37. Tenover F. C., Arbeit R. D., Goering R. V., Mickelsen P. A., Murray B. E., Persing D. H., Swaminathan B. 1995; Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233–2239[PubMed]
    [Google Scholar]
  38. Truog W. E., Davis R. F., Ray C. G. 1976; Recurrence of group B streptococcal infection. J Pediatr 89:185–186 [View Article][PubMed]
    [Google Scholar]
  39. Udo E. E., Al-Sweih N., John P., Jacob L. E., Mohanakrishnan S. 2004; Characterization of high-level aminoglycoside-resistant enterococci in Kuwait hospitals. Microb Drug Resist 10:139–145 [View Article][PubMed]
    [Google Scholar]
  40. Uh Y., Jang I. H., Hwang G. Y., Yoon K. J., Song W. 2001; Emerging erythromycin resistance among group B streptococci in Korea. Eur J Clin Microbiol Infect Dis 20:52–54 [View Article][PubMed]
    [Google Scholar]
  41. Victor N., Rubens C. E. 2000; Pathogenic mechanisms and virulence factors of group B streptococci. In Gram-positive Pathogens pp. 125–136 Edited by Fischetti V. A., Novick R. P., Ferretti J. J., Portnoy D. A., Rood J. I. Washington, DC: ASM Press;
    [Google Scholar]
  42. Wu H. M., Janapatla R. P., Ho Y. R., Hung K. H., Wu C. W., Yan J. J., Wu J. J. 2008; Emergence of fluoroquinolone resistance in group B streptococcal isolates in Taiwan. Antimicrob Agents Chemother 52:1888–1890 [View Article][PubMed]
    [Google Scholar]
  43. Zeng X., Kong F., Wang H., Darbar A., Gilbert G. L. 2006; Simultaneous detection of nine antibiotic resistance-related genes in Streptococcus agalactiae using multiplex PCR and reverse line blot hybridization assay. Antimicrob Agents Chemother 50:204–209 [View Article][PubMed]
    [Google Scholar]
  44. Zhao Z., Kong F., Zeng X., Gidding H. F., Morgan J., Gilbert G. L. 2008; Distribution of genotypes and antibiotic resistance genes among invasive Streptococcus agalactiae (group B streptococcus) isolates from Australasian patients belonging to different age groups. Clin Microbiol Infect 14:260–267 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.035477-0
Loading
/content/journal/jmm/10.1099/jmm.0.035477-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed